Human leukemia antigens: partial isolation and characterization.
D000818:Animals; D000951:Antigens, Neoplasm / Q000302:isolation & purification*; D002460:Cell Line; D002462:Cell Membrane / Q000276:immunology; D002498:Centrifugation; D002850:Chromatography, Gel; D003513:Cycloheximide / Q000494:pharmacology; D003561:Cytarabine / Q000494:pharmacology; D003601:Cytotoxicity Tests, Immunologic; D003609:Dactinomycin / Q000494:pharmacology; D000882:Haplorhini / Q000276:immunology; D006649:Histocompatibility Antigens / Q000302:isolation & purification; D006801:Humans; D007106:Immune Sera; D007938:Leukemia / Q000276:immunology*; D007945:Leukemia, Lymphoid / Q000276:immunology; D007951:Leukemia, Myeloid / Q000276:immunology; D015470:Leukemia, Myeloid, Acute / Q000276:immunology; D007962:Leukocytes / Q000276:immunology*; D008214:Lymphocytes / Q000276:immunology; D008854:Microscopy, Electron; D009439:Neuraminidase / Q000494:pharmacology; D010206:Papain; D011189:Potassium Chloride; D011402:Pronase; D011691:Puromycin / Q000494:pharmacology; D011817:Rabbits / Q000276:immunology; D013347:Subcellular Fractions; D013696:Temperature; D014357:Trypsin
D000951:Antigens, Neoplasm; D006649:Histocompatibility Antigens; D007106:Immune Sera; D003561:Cytarabine; D003609:Dactinomycin; D011691:Puromycin; D011189:Potassium Chloride; D003513:Cycloheximide; D009439:Neuraminidase; D014357:Trypsin; D010206:Papain; D011402:Pronase